ARCHIVES

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

This article is from The Cancer Letter archive.

Vol. 12 No. 16 | April 18, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

ACS Modifies Mammography Guidelines

August 5, 1983

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

TCGA Researchers Discover Stomach Cancer Falls Into Four Distinct Molecular Subtypes

August 29, 2014

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005